Medical Device Studies: Clinical Evidence

Nov 25th, 2014Nov 26th, 2014
London, --
GB
http://www.management-forum.co.uk/medical/eventid/2622
Phone:+44 (0) 1473 730071
A course on gathering and using clinical evidence for CE marking and postmarket compliance.
Latest in Home
Brain PET/CT imaging is one of the diagnostic applications of nuclear medicine.
European Nuclear Medicine Day to tackle access gaps across Europe
September 25, 2026
Shutterstock 2670403783
GPR 2026 opening day: Benefit before novelty in pediatric radiology
September 24, 2026
Photon-counting CT correctly identified ≥50% in-stent restenosis in the mid-right coronary artery, which was confirmed by invasive angiography.
Photon-counting CT may widen noninvasive follow-up after coronary stenting
September 23, 2026
Ac20bd19 9a51 42ad 99c0 7fd5c5051ff9
SPECT/CT holds ground as PET advances cardiac amyloidosis imaging
September 22, 2026
More in Home
European Nuclear Medicine Day to tackle access gaps across Europe
By Claudia Tschabuschnig
EANM and Nuclear Medicine Europe will bring policymakers, clinicians, industry, and patients together in Brussels on 29 September to push for more equitable access to nuclear medicine across Europe.
September 25, 2026
Brain PET/CT imaging is one of the diagnostic applications of nuclear medicine.
GPR 2026 opening day: Benefit before novelty in pediatric radiology
By Claudia Tschabuschnig
Reducing radiation, sedation, contrast use, and examination time will be among the major themes at GPR 2026, as pediatric radiologists meet in Tübingen.
September 24, 2026
Shutterstock 2670403783
Photon-counting CT may widen noninvasive follow-up after coronary stenting
By Claudia Tschabuschnig
An Austrian study found photon-counting CT sharply reduced nondiagnostic coronary stents and showed promising rule-out performance for significant in-stent restenosis.
September 23, 2026
Photon-counting CT correctly identified ≥50% in-stent restenosis in the mid-right coronary artery, which was confirmed by invasive angiography.
SPECT/CT holds ground as PET advances cardiac amyloidosis imaging
By Claudia Tschabuschnig
Experts discussed how SPECT/CT remains central to ATTR cardiac amyloidosis diagnosis, while emerging PET tracers could allow more direct imaging of amyloid deposits.
September 22, 2026
Ac20bd19 9a51 42ad 99c0 7fd5c5051ff9
ESHNR strengthens year-round education in head and neck radiology
By Claudia Tschabuschnig
With webinars, a masterclass, and expanding mentoring initiatives, ESHNR is extending head and neck radiology education.
September 22, 2026
mentor
Telix signs agreement to acquire ITM
By Erik L. Ridley
The deal would create a combined company with significant radioisotope manufacturing, distribution, and radiopharmaceutical development capabilities.
September 21, 2026
Isotopes1
Sustainability in cancer care: from machines to systems
By Claudia Tschabuschnig
Speakers at a session at the IAEA Scientific Forum asked what remains after the machine has been installed.
September 21, 2026
Screenshot 2026 09 21 202952
Les patients d’abord! Patients first at this year’s JFR meeting
By Frances Rylands-Monk
JFR president Prof. Isabelle Thomassin-Naggara discusses the importance of the human radiologist for patients, a key theme at this year’s congress.
September 18, 2026
Photo illustrating eco-responsibility, a theme that the SFR continues to champion at the JFR. The photograph shows a paper flower made by a patient (www.poeticmood.fr) who will be running craft workshops at the Patient Associations’ Village during JFR 2026. Participants will be invited to create their own JFR 2026 flower and take it home.
IAEA Scientific Forum: Can automated planning shorten radiotherapy waits?
By Claudia Tschabuschnig
Research promising one-second treatment planning prompted discussion of workforce shortages and delays in cancer care at the IAEA Scientific Forum in Vienna.
September 17, 2026
Whats App Image 2026 09 17 At 15 24 59
Radiation medicine aims to tackle cancer care inequalities in low-income countries
By Claudia Tschabuschnig
Health experts discussed challenges facing cancer care in low income countries, the potential of theranostics as well as AI, covering various topics to bridge global health disparities at the IAEA Scientific Forum in Vienna.
September 16, 2026
From left: moderator Christine Mhundwa with Dr. Claudio Tinoco Mesquita, Dr. Ariel Fariña Barrios, Dr. Dina Husseiny Salama, Dr. Umesh Mahantshetty, Dr. Ellen Kampman and Dr. Alejandro Mazal.
IAEA Scientific Forum: Where you live should not determine access to cancer care
By Claudia Tschabuschnig
At the IAEA Scientific Forum in Vienna, politicians, health policymakers, ministers, and physicians came with a bunch of numbers on the stark differences in access to radiotherapy, nuclear medicine, and medical imaging, especially in low and middle income countries.
September 15, 2026
Whats App Image 2026 09 15 At 20 00 14
CIRSE: Studies link ablation margins to liver tumor control
By Claudia Tschabuschnig
Two studies presented at CIRSE 2026 linked adequate ablation margins to better liver tumor control. Measuring those margins consistently remains a challenge.
September 14, 2026
Gonnie van Erp: “We still see interobserver differences in margin assessment.”
Page 1 of 93
Next Page